A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
- Tim West
- , Kristopher M. Kirmess
- , Matthew R. Meyer
- , Mary S. Holubasch
- , Stephanie S. Knapik
- , Yan Hu
- , John H. Contois
- , Erin N. Jackson
- , Scott E. Harpstrite
- , Randall J. Bateman
- , David M. Holtzman
- , Philip B. Verghese
- , Ilana Fogelman
- , Joel B. Braunstein
- , Kevin E. Yarasheski
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Hope Center for Neurological Disorders
- Bursky Center for Human Immunology and Immunotherapy
- Center for Brain Immunology & Glia (BIG)
- Department of Neurology
- DBBS - Neurosciences
- DBBS - Biomedical Informatics and Data Science
- DBBS - Molecular Cell Biology
- Intellectual and Developmental Disabilities Research Center (IDDRC)
Research output: Contribution to journal › Article › peer-review
194
Link opens in a new tab
Scopus
citations